BLCO · ISSUER CIK 1860742
Bausch & Lomb Corp
Between Aug 1, 2026 and Oct 29, 2026, 11 Bausch & Lomb Corp insiders reported $0.00 of open-market purchases and $1.2M of sales on SEC Form 4.
↗11 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 2 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$1.2MInsider selling
−$1.2MNet open-market
Aug 14, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 202617:47 | Aug 12, 2026 | BLCO | Director | A · Grant | — | +11,776 | 11,776 | New | — | ||
| Aug 14, 202617:34 | Aug 12, 2026 | BLCO | Director | A · Grant | — | +11,776 | 11,776 | New | — | ||
| Aug 14, 202617:25 | Aug 12, 2026 | BLCO | Director | A · Grant | — | +11,776 | 11,776 | New | — | ||
| Aug 12, 202619:06 | Aug 10, 2026 | BLCO | SVP, Controller and CAO | S · Sell | $16.78 | −52,900 | 45,831 | -54% | −$888K | ||
| Aug 10, 202620:57 | Aug 7, 2026from Aug 6, 2026 | BLCO | Director | S · Sell | $16.53 | −18,559 | 63,733 | -23% | −$307K | ||
| Aug 7, 202616:54 | Aug 5, 2026 | BLCO | President, GPIC | A · Grant | — | +16,778 | 103,211 | +19% | — | ||
| Aug 7, 202616:53 | Aug 5, 2026 | BLCO | SVP, Controller and CAO | A · Grant | — | +9,091 | 98,731 | +10% | — | ||
| Aug 7, 202616:50 | Aug 5, 2026 | BLCO | EVP of R&D and CMO | A · Grant | — | +20,973 | 187,350 | +13% | — | ||
| Aug 7, 202616:42 | Aug 5, 2026 | BLCO | EVP and CFO | A · Grant | — | +50,335 | 393,527 | +15% | — | ||
| Aug 7, 202616:35 | Aug 5, 2026 | BLCO | President, Surgical | A · Grant | — | +16,778 | 103,801 | +19% | — | ||
| Aug 7, 202616:32 | Aug 5, 2026 | BLCO | EVP & Chief Legal Officer | A · Grant | — | +33,557 | 264,241 | +15% | — | ||
| Aug 7, 202616:30 | Aug 5, 2026 | BLCO | Chairman of the Board and CEO, Director | F · Tax | $16.76 | −4,231 | 974,158 | -0% | $71K | ||
| Aug 7, 202616:30 | Aug 5, 2026 | BLCO | Chairman of the Board and CEO, Director | A · Grant | — | +281,879 | 1,256,037 | +29% | — |